Skip Navigation



British Medical Bulletin Advance Access published online on October 29, 2009
British Medical Bulletin, doi:10.1093/bmb/ldp037
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Pollock, E.
Right arrow Articles by Gkrania-Klotsas, E.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pollock, E.
Right arrow Articles by Gkrania-Klotsas, E.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2009. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oxfordjournals.org

Bone health in HIV infection

Emily Pollock{dagger}, Angelos-Emmanouil Klotsas{ddagger}, Juliet Compston§ and Effrossyni Gkrania-Klotsas,*

{dagger} Clinical School of Medicine, University of Cambridge, Cambridge, UK
{ddagger} Department of Endocrinology and Diabetes, Luton and Dunstable Hospital, Luton, UK
§ Clinical School of Medicine and Addenbrooke's Hospital, Box 157, Cambridge, UK
Department of Infectious Diseases, Addenbrooke's Hospital, Box 153, Cambridge CB2 2QQ, UK

* Correspondence to: Effrossyni Gkrania-Klotsas, Department of Infectious Diseases, Addenbrooke's Hospital, Box 153, Hills Road, Cambridge CB2 2QQ, UK. E-mail: eg318{at}cam.ac.uk

Introduction: Osteoporosis is among the chronic problems emerging as the human immunodeficiency virus (HIV)-positive population ages.

Sources of data: We reviewed the English language bibliography using Pubmed 2.0, Web of Science and Embase for relevant abstracts and articles.

Areas of agreement: The prevalence of low bone mineral density (BMD) and fracture is increased in the HIV-positive population.

Areas of controversy: The pathogenesis is multifactorial; there is some evidence that HIV infection is an independent risk factor and that highly active antiretroviral therapy has adverse skeletal effects.

Growing points: Physicians should routinely review the bone health of all HIV patients.

Areas timely for developing research: More studies of the mechanisms of bone loss, the skeletal effects of antiretroviral therapy and the therapeutic outcome of bone-protective therapy in HIV-positive individuals are needed.

Keywords: HIV • AIDS • osteoporosis • fracture • vitamin D • bisphosphonates • bone mineral density • antiretroviral

Accepted for publication September 21, 2009.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.